Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

2 Ark ETFs Offering Good Value After This Year’s Selloff

By Tezcan Gecgil/Investing.com ETFsJul 26, 2022 04:38AM ET
www.investing.com/analysis/2-ark-etfsoffering-good-value-after-this-years-selloff-200627598
2 Ark ETFs Offering Good Value After This Year’s Selloff
By Tezcan Gecgil/Investing.com   |  Jul 26, 2022 04:38AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
ARKG
+0.40%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ARKF
+1.17%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IONS
-1.45%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
EXAS
+2.34%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
FATE
-2.31%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MIWD0...
+2.15%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
  • Cathie Wood announced the upcoming closure of the ARK Transparency ETF
  • Despite declines, investors continue to follow Wood’s holdings closely
  • Consider 2 Ark Invest ETFs that offer better value compared to a year ago

After causing great excitement during the pandemic, many stocks held in Cathie Wood’s Ark Invest exchange-traded funds (ETFs) have come under fire since January.

So far in the year, dramatic spikes in inflation, rising interest rates, and geopolitical concerns have taken a heavy toll on growth stocks. Recent data from Bloomberg Intelligence highlights Wood’s funds saw “the most significant decline of the 25 largest US issuers…but Wood and Ark have a loyal following.”

Meanwhile, Ark Invest recently announced the upcoming closure of the ARK Transparency ETF (NYSE:CTRU). The fund tracked the Transparency Index, the 100 most transparent companies compiled by Transparency Global.

In a press release, Ark Invest reported that Transparency Global would no longer calculate the Transparency Index, and thus it could not find a suitable replacement. ARK Transparency ETF was launched in December 2021 and has lost close to a third of its value so far.

Despite the upcoming closure of the CTRU fund, Wood’s followers are keeping a close eye on other ETFs offered by Ark Invest. Today, we introduce two of those funds.

1. ARK Fintech Innovation ETF

  • Current Price: $17.69
  • 52-week range: $14.64 - $55.28
  • Expense ratio: 0.75% per year

Metrics suggest, by 2026, the global financial technology (fintech) market size will approach $325 billion. Such an expansion from the current levels would mean a compound annual growth rate (CAGR) of over 25% between 2022 and 2027.

The first fund we will be discussing is the ARK Fintech Innovation ETF (NYSE:ARKF), which invests in names that are leading the developments in fintech. The fund started trading in February 2019.

ARKF Weekly
ARKF Weekly

ARKF, which tracks the MSCI World Index, typically holds between 35-55 stocks. With regards to sub-sector breakdown, we see Transaction Innovations (31.3%), Customer Facing Platforms (18.5%), The New Intermediaries (15.9%), Risk Transformations (14.3%), and others.

Close to 70% of the companies come from North America. Next, we see businesses from South & Central America, Asia-Pacific, Africa/Middle East, Western Europe, and Central Asia.

The top 10 stocks in the portfolio represent almost two-thirds of net assets of $811.2 million. Among them are Block (NYSE:SQ), which offers a large payments ecosystem; e-commerce platform provider Shopify (NYSE:SHOP); cryptocurrency exchange Coinbase Global (NASDAQ:COIN); cloud communications platform Twilio (NYSE:TWLO); and no-coding automation platform Uipath (NYSE:PATH).

ARKF saw a record high in February 2021. Since then, investors have been concerned about valuations in the industry. As a result, the ETF is down around 56.6% year-to-date (YTD). Despite the recent declines, many companies in ARKF are seeing impressive top-line growth. Long-term investors should find value in these fintech leaders around these levels.

2. ARK Genomic Revolution ETF

  • Current Price: $36.71
  • 52-week range: $26.38 -$89.11
  • Expense ratio: 0.75% per year

Cathie Wood pays close attention to developments in genomics, or the “study of the body’s genes, their functions and their influence on the growth, development and working of the body.” Between 2021-2028, the global genomics market is forecast to grow at a CAGR of well over 19% and reach almost $95 billion in 2028.

Next up on our list of funds is the ARK Genomic Revolution ETF (NYSE:ARKG). The fund was first listed in October 2014, and assets stand at $2.34 billion. It invests in a diverse range of companies that make genomics a significant part of their businesses. Some of the technologies in focus include CRISPR, bioinformatics, molecular diagnostics, targeted therapeutics, oncology, stem cells, and agricultural biology.

ARKG Weekly
ARKG Weekly

ARKG currently holds 40 stocks. Health care names have the largest slice, with 91.9%, followed by information technology (5.4%) and materials (2.5%).

Over 95% of the companies come from North America. Close to half of the portfolio is concentrated in the leading 10 stocks.

Cancer diagnostics company Exact Sciences (NASDAQ:EXAS); Teladoc Health (NYSE:TDOC), which offers virtual healthcare services; Ionis Pharmaceuticals (NASDAQ:IONS), known for its spinal muscular atrophy drug Spinraza; Fate Therapeutics (NASDAQ:FATE), which develops cellular immunotherapies, especially against cancer; and gene-editing company Crispr Therapeutics (NASDAQ:CRSP) make up for the most significant part of the fund.

ARKG saw a 52-week high in early August 2021. But it has lost 57% in the past 52 weeks and 40% since January. Those investors looking to include a biotech ETF, especially one that focuses on genomics, should do further due diligence on ARKG.

Disclaimer: On the date of publication, Tezcan Gecgil, Ph.D., did not have any positions in the securities mentioned in this article.

2 Ark ETFs Offering Good Value After This Year’s Selloff
 

Related Articles

Tim Knight
ETF Focus: Commodities By Tim Knight - Nov 13, 2022 1

Let’s look at a few commodity ETFs together. In general, they have remained in an uptrend for two years. This channel needs to break in order for commodities to start a downtrend,...

2 Ark ETFs Offering Good Value After This Year’s Selloff

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Zu Zar
Zu Zar Jul 26, 2022 11:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks
Stuart Laubscher
Stuey Jul 26, 2022 11:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
With all due respect to any parties involved, in 2021 it was a bull rush, after chasing, the US indices, for the day, on scalping. You could open a long, and wake up better off! Why did C.Woods dump her own stock, as well as double down ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email